Similarly, our study demonstrated that the expression of membrane-bound RhoA protein was down-regulated by EphA2 siRNA in non-metastatic RCC cells, suggesting that RhoA could be a downstream effector of EphA2. Here, EPHA2 is linked to renal cell carcinoma.